If Donald Trump returns to the White House, the self-proclaimed master negotiator could get his shot at brokering Medicare prices for drugs.
But the Democrats' drug pricing law would require the GOP frontrunner to negotiate Medicare prices for some drugs if he wins a second term, and former Trump health officials expect he would use executive power to soften the government's approach.
Future administrations won't have much flexibility to dismantle or ignore Medicare drug price negotiations without a change from Congress. The Inflation Reduction Act sets out how many drugs Medicare must negotiate, what factors it should consider, and the types of drugs up for negotiations. But Medicare has discretion in how it determines the negotiated price - and that's where Trump or another Republican administration would have leeway to dial back negotiating powers.
[
add
]
[
|
|
...
]